跳至主要内容
临床试验/NCT02660658
NCT02660658Unknown不适用

Optimal Single-dose Intrathecal Dexmedetomidine for Postoperative Analgesia After Lower Limb Surgery

Mansoura University1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2016年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
15
试验地点
1
主要终点
Duration of analgesia

研究概览

简要总结

Spinal anesthesia is a commonly used technique for lower limb surgeries offering better quality of postoperative analgesia, lower incidence of side effects, and shorter post-anesthesia care unit stay than general anesthesia. However, the relatively short duration of action of the currently available local anesthetics (LAs) make these advantages short-lived.

The risk for local anesthetic toxicity (LAST) increases with the trials to use higher concentrations or volumes of intrathecal local anesthetics to increase the duration of analgesia.

Dexmedetomidine has the potential to prolong the duration of perioperative analgesia without the need for using high doses of local anesthetics and hence with decreasing the potential risk of local anesthetic, but the increased likelihood adverse effects such as short term bradycardia and prolonged duration of motor block may offset these benefits.

详细描述

The aim of this study is to determine the optimal single-dose of intrathecal dexmedetomidine that prolongs the analgesic duration with the least possible side effects.

With the patients in the sitting position and the use of complete aseptic technique, 25G Whitacre spinal needles will be introduced through L2-L4 interspaces and after observing free flow of the CSF, a 3ml volume including bupivacaine 12.5mg in conjunction with dexmedetomidine (3 µg) will be injected in the first case, then the patient will be turned supine.

The dose of intrathecal DEX given to the next patient will be guided by modified Dixon's up-and-down method using 1.5 mg as a step size, which assumed to be of clinical importance.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • American Society of Anesthesiologists physical class I to II.
  • Patients scheduled for elective lower limb surgeries.

排除标准

  • Morbid obese patients.
  • Severe or uncompensated cardiovascular disease.
  • Significant renal disease.
  • Significant hepatic disease.
  • Pregnancy.
  • Lactating .
  • Heart block.
  • Bradyarrhythmias.
  • Receiving adrenergic receptor antagonist medications.
  • Receiving calcium channel blockers.
  • Patients with pacemakers.
  • Patients with implanted cardioverter defibrillator.
  • Allergy to the study medications.
  • Psychological disease.
  • Neurological disorders.
  • Communication barrier.
  • Mental disorders.
  • Epilepsy.
  • Drug or alcohol abuse.
  • Contraindications to spinal anaesthesia.
  • Receiving opioid analgesic medications within 24 h before the operation.

研究组 & 干预措施

Intrathecal dexmedetomidine

Other

Up-down sequential allocation

The dose of intrathecal DEX given to the next patient will be guided by modified Dixon's up-and-down method using 1.5 mg as a step size, which assumed to be of clinical importance

干预措施: Intrathecal dexmedetomidine (Drug)

结局指标

主要结局

Duration of analgesia

时间窗: For 13 hours after surgery

The duration of analgesia, defined as the time from administering of intrathecal study solution (T0) to the time for the first rescue analgesic request

次要结局

  • Cumulative tramadol consumption(For 24 hours after surgery)
  • Onset of motor blockade(For 2 hours after initiation of spinal anesthesia)
  • Postoperative pain score(For 24 hours after surgery)
  • Onset of sensory blockade(For 1 hour after initiaion of spinal anesthesia)
  • Highest dermatome level of sensory blockade(For 4 hours after initiation of spinal anesthesia)
  • Time to motor regression(For 6 hours after initiation of spinal anesthesia)
  • Sedation score(For 24 hours after initiation of spinal anesthesia)
  • Postoperative nausea and vomiting(For 24 hours after initiation of spinal anesthesia)
  • Intraoperative bradycardia(For 4 hours after initiation of spinal anesthesia)
  • Intraoperative use of supplemental fentanyl(For 4 hours after initiation of spinal anesthesia)
  • Intraoperative use of ephedrine(For 4 hours after initiation of spinal anesthesia)
  • Intraoperative use of midazolam(For 4 hours after initiation of spinal anesthesia)
  • Intraoperative use of atropine(For 4 hours after initiation of spinal anesthesia)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验